Citadel Advisors’s Keryx Biopharmaceuticals Inc KERX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2018
Q4 | – | Sell |
-44,686
| Closed | -$152K | – | 5231 |
|
|
2018
Q3 | $152K | Sell |
44,686
-83,417
| -65% | -$284K | ﹤0.01% | 3824 |
|
|
2018
Q2 | $482K | Buy |
128,103
+88,501
| +223% | +$333K | ﹤0.01% | 3155 |
|
|
2018
Q1 | $162K | Sell |
39,602
-201,070
| -84% | -$823K | ﹤0.01% | 3537 |
|
|
2017
Q4 | $1.12M | Buy |
240,672
+89,889
| +60% | +$418K | ﹤0.01% | 2320 |
|
|
2017
Q3 | $1.07M | Buy |
150,783
+42,668
| +39% | +$303K | ﹤0.01% | 2228 |
|
|
2017
Q2 | $782K | Sell |
108,115
-40,051
| -27% | -$290K | ﹤0.01% | 2327 |
|
|
2017
Q1 | $912K | Buy |
148,166
+100,857
| +213% | +$621K | ﹤0.01% | 2213 |
|
|
2016
Q4 | $277K | Buy |
+47,309
| New | +$277K | ﹤0.01% | 2861 |
|
|
2016
Q3 | – | Sell |
-163,016
| Closed | -$1.08M | – | 4349 |
|
|
2016
Q2 | $1.08M | Buy |
163,016
+70,066
| +75% | +$464K | ﹤0.01% | 1782 |
|
|
2016
Q1 | $434K | Buy |
92,950
+92,949
| +9,294,900% | +$434K | ﹤0.01% | 2299 |
|
|
2015
Q4 | $0 | Sell |
1
-41,351
| -100% | – | ﹤0.01% | 4487 |
|
|
2015
Q3 | $146K | Buy |
41,352
+15,079
| +57% | +$53.2K | ﹤0.01% | 3292 |
|
|
2015
Q2 | $262K | Sell |
26,273
-626
| -2% | -$6.24K | ﹤0.01% | 2912 |
|
|
2015
Q1 | $342K | Sell |
26,899
-88,094
| -77% | -$1.12M | ﹤0.01% | 2863 |
|
|
2014
Q4 | $1.63M | Sell |
114,993
-112,894
| -50% | -$1.6M | ﹤0.01% | 1797 |
|
|
2014
Q3 | $3.13M | Buy |
227,887
+209,075
| +1,111% | +$2.87M | ﹤0.01% | 1364 |
|
|
2014
Q2 | $289K | Sell |
18,812
-187,149
| -91% | -$2.88M | ﹤0.01% | 2617 |
|
|
2014
Q1 | $3.51M | Buy |
205,961
+37,224
| +22% | +$634K | ﹤0.01% | 1212 |
|
|
2013
Q4 | $2.19M | Buy |
168,737
+126,900
| +303% | +$1.64M | ﹤0.01% | 1317 |
|
|
2013
Q3 | $423K | Sell |
41,837
-21,284
| -34% | -$215K | ﹤0.01% | 1967 |
|
|
2013
Q2 | $472K | Buy |
+63,121
| New | +$472K | ﹤0.01% | 1956 |
|